# Research Idea Ranking

**Generated:** 2026-02-06T11:46:13.229498
**Model:** openai/gpt-5.2 (reasoning: high)
**Tokens:** 7740

---

### Rankings

**#1: Digital Exodus or Digital Magnet? How State Data Privacy Laws Reshape the Tech Sector (Idea 1)**  
- **Score: 74/100**  
- **Strengths:** Strong outcome measurement (BFS/QCEW) with high-frequency data and a large number of treated states; the sectoral “sorting” prediction is a genuinely testable mechanism rather than a vague reduced-form exercise. Effective dates are fairly well-defined, enabling credible event studies if timing is handled carefully.  
- **Concerns:** Adoption is politically endogenous (and correlated with tech intensity), so pre-trends and differential shocks (COVID, remote-work migration, state tax changes) are real threats; IRS SOI migration won’t cleanly isolate “tech workers,” so that component risks weak interpretation.  
- **Novelty Assessment:** **Moderately novel.** There is growing privacy-law work (esp. CCPA/Europe GDPR analogies), but the **within-tech compositional/sorting** angle using **BFS + QCEW subindustries** is less saturated than “average effect on firms.”  
- **DiD Assessment:**  
  - **Pre-treatment periods:** **Strong** (BFS monthly from 2015 gives long pre for most adoptions; QCEW also long pre).  
  - **Selection into treatment:** **Marginal** (privacy laws correlate with ideology, consumer preferences, tech presence; not random).  
  - **Comparison group:** **Marginal** (never-treated states may differ systematically; but with 20+ treated, you can use not-yet-treated and do balance/weighting).  
  - **Treatment clusters:** **Strong** (20+ states).  
  - **Concurrent policies:** **Marginal** (COVID/remote work, state tax changes, other tech regs; must control/check).  
  - **Outcome-Policy Alignment:** **Strong** (laws directly change compliance costs/consumer trust in data-intensive sectors; NAICS 51/5415 outcomes map to the mechanism).  
  - **Data-Outcome Timing:** **Marginal** (many effective dates are **mid-year**—e.g., **July**; QCEW is quarterly and BFS is monthly, so you must define exposure windows: drop partial months/quarters or code treatment as “fully treated” only after a full month/quarter).  
  - **Outcome Dilution:** **Marginal** (within NAICS 51/5415, many firms are affected, but not all; effects may concentrate in ad tech/data brokers which are a subset—use finer NAICS where possible).  
- **Recommendation:** **PURSUE (conditional on: (i) explicit timing/exposure coding for July/Dec effective dates; (ii) strong pre-trend/event-study diagnostics and possibly weighting/matching to improve treated/control comparability; (iii) treat IRS migration as ancillary unless you can better proxy tech workers, e.g., focus on top AGI + high-tech counties).**

---

**#2: Do State Drug Policy Reforms Change Health-Seeking Behavior? Evidence from Google Trends (Idea 4)**  
- **Score: 63/100**  
- **Strengths:** Very feasible, high-frequency panel with many policy changes and long pre-periods; good for mechanism/timing tests (immediate vs gradual responses) and heterogeneous effects across policies/terms.  
- **Concerns:** Google Trends indices are noisy/normalized (measurement and comparability issues), and policy adoption—especially opioid policies—can respond to worsening local crises, making selection/pre-trends the key fragility.  
- **Novelty Assessment:** **Moderate.** Google Trends is widely used, and marijuana-related search papers exist, but the *explicit “stigma reduction vs normalization”* framing across multiple drug-policy domains is less standard.  
- **DiD Assessment:**  
  - **Pre-treatment periods:** **Strong** (weekly Trends data exist for many years pre; most policies have ample pre).  
  - **Selection into treatment:** **Marginal** (Good Samaritan/naloxone/PDMP often respond to the opioid epidemic; legalization is political. You’ll need strong pre-trend/event-study evidence and maybe controls for overdose trends/media shocks).  
  - **Comparison group:** **Marginal** (states differ in baseline drug burden; can improve via region-by-time controls, weighting, or border-county designs if you can credibly construct them with Trends).  
  - **Treatment clusters:** **Strong** (24+ / 30+ / 40+ states depending on policy).  
  - **Concurrent policies:** **Marginal** (opioid policies bundle together; marijuana legalization coincides with dispensary rollout/taxation—requires multi-policy modeling and careful interpretation).  
  - **Outcome-Policy Alignment:** **Marginal** (searches are a proxy for “health-seeking,” not utilization; but the proxy is conceptually linked to stigma/information and can be validated against admissions/claims in robustness checks).  
  - **Data-Outcome Timing:** **Strong** (weekly data allows tight event windows around effective dates; you can exclude partial weeks and test anticipation).  
  - **Outcome Dilution:** **Marginal** (affected individuals are a minority, but policy salience can shift broad search behavior; still, effects may be small and noisy).  
- **Recommendation:** **CONSIDER (conditional on: (i) pre-registering term lists and validating against at least one “real” outcome series—treatment admissions, overdoses, naloxone fills; (ii) addressing Google Trends normalization by using within-state scaling strategies, placebo terms, and stability checks).**

---

**#3: The Banking Desert Paradox: How Cannabis Legalization Reduces Financial Access (Idea 5)**  
- **Score: 49/100**  
- **Strengths:** Excellent administrative data (FDIC Summary of Deposits) with long history; the “federal illegality → banking retreat” mechanism is policy-relevant and plausibly testable with geography.  
- **Concerns:** As currently framed at the **state-year** level, this is at high risk of **outcome dilution** (effects likely localized near dispensaries) and **timing mismatch** (FDIC SoD is a **June 30** snapshot; many legalizations/market openings occur later), plus strong secular downward trends in branching.  
- **Novelty Assessment:** **Moderate.** There’s a sizable cannabis-economics literature and some work on banking/financial frictions, but “branch entry/exit and local access” tied to legalization is less crowded than crime/usage/tax revenue.  
- **DiD Assessment:**  
  - **Pre-treatment periods:** **Strong** (1994–present annual branch snapshots).  
  - **Selection into treatment:** **Marginal** (legalization is political and correlated with urbanization/growth; manageable with event studies + covariates, but not clean).  
  - **Comparison group:** **Marginal** (never-treated states differ; not-yet-treated helps, but trends differ a lot).  
  - **Treatment clusters:** **Strong** (24 states).  
  - **Concurrent policies:** **Marginal** (bank consolidation, fintech adoption, COVID branch closures; cannabis rollout specifics vary).  
  - **Outcome-Policy Alignment:** **Marginal** (branch counts are an indirect measure of “financial access”; the mechanism is about compliance risk near cannabis cash activity—better captured by local branch behavior near dispensaries).  
  - **Data-Outcome Timing:** **Weak** *(dealbreaker as written)* — FDIC SoD is measured **June 30** each year; legalization effective dates and (more importantly) **retail sales start dates** often occur **after** June 30 or with long lags, so the first “treated” observation may have little/no exposure.  
  - **Outcome Dilution:** **Weak** *(dealbreaker as written)* — if the effect is concentrated in dispensary-dense metros/corridors, state averages will wash it out (<10–20% of branches/areas meaningfully exposed).  
- **Recommendation:** **SKIP (unless redesigned).** A viable redesign would be **branch-level/county-level DiD** using distance to dispensaries (or licenses) and using **retail-sales start dates**; otherwise you are very likely to estimate nulls driven by dilution/timing.

---

**#4: The Cost of Ideology: How Anti-ESG Laws Raise Government Borrowing Costs (Idea 2)**  
- **Score: 41/100**  
- **Strengths:** High policy salience and clear welfare framing (reduced competition → higher financing costs); multi-state scope would add value relative to single-state case studies.  
- **Concerns:** The proposed outcome (annual **interest expenditures**) is a poor/lagged proxy for marginal borrowing costs, and credible state-level yield data are nontrivial; adoption is highly political and clustered in 2023 amid large national rate shocks.  
- **Novelty Assessment:** **Somewhat studied and rapidly growing.** Not “100 papers,” but enough recent policy reports/working papers (esp. Texas) that novelty is not the main advantage.  
- **DiD Assessment:**  
  - **Pre-treatment periods:** **Strong** (government finance series go back many years).  
  - **Selection into treatment:** **Marginal** (ideological/political adoption; possibly correlated with fiscal structure).  
  - **Comparison group:** **Marginal** (treated states are disproportionately conservative/energy-heavy; never-treated differ).  
  - **Treatment clusters:** **Marginal** (≈15 states—borderline for inference, especially with bunching).  
  - **Concurrent policies:** **Weak** — 2022–2024 features major confounders for borrowing costs (Fed tightening, inflation shocks) and other state fiscal changes; hard to separate without security-level yield data and issuance controls.  
  - **Outcome-Policy Alignment:** **Weak** — interest expenditure reflects legacy debt portfolios, maturity structure, refinancing, and accounting; the policy mechanism operates through **primary-market yields/spreads at issuance**, not near-term total interest spending.  
  - **Data-Outcome Timing:** **Weak** — even if yields rise immediately, interest expenditures may not move for years (until rollover/refinancing), creating mechanical attenuation and mis-timed “effects.”  
  - **Outcome Dilution:** **Marginal** (only new issuance is affected; annual interest spending mostly reflects old debt).  
- **Recommendation:** **SKIP** as proposed. This becomes credible only if you pivot to **bond-level yields/spreads at issuance** (MSRB/EMMA) with careful issuance controls and enough clusters/time.

---

**#5: Lights Out for Green? Renewable Energy Mandates and Power Grid Reliability (Idea 3)**  
- **Score: 28/100**  
- **Strengths:** The outcome data (EAGLE-I, high-frequency outages) are excellent and policy-relevant; reliability is a first-order concern and the “when outages occur” angle is interesting.  
- **Concerns:** The DiD design is fundamentally misaligned: most RPS adoptions occurred **well before** the outage data begin (2014), leaving many treated units with **no pre-period** and turning the design into comparisons among “already-treated” states.  
- **Novelty Assessment:** **Low-to-moderate.** RPS effects on electricity markets/emissions/prices are heavily studied; reliability is less settled, but not untouched. The main novelty here is the EAGLE-I outage granularity—not the policy question itself.  
- **DiD Assessment:**  
  - **Pre-treatment periods:** **Weak** — for early adopters (many RPS states adopted 1997–2005), EAGLE-I starts 2014, so you cannot test pre-trends around adoption.  
  - **Selection into treatment:** **Marginal** (policy adoption reflects politics/resource mix; plausible correlation with grid characteristics).  
  - **Comparison group:** **Weak** — never-RPS states are systematically different (often South/Plains) in grid interconnections, weather exposure, regulation, and generation mix.  
  - **Treatment clusters:** **Strong** (30+ states), but this doesn’t rescue missing pre-periods.  
  - **Concurrent policies:** **Weak** — reliability is driven by storms, wildfires, grid investment, market reforms, and climate trends that differ sharply across states and time.  
  - **Outcome-Policy Alignment:** **Strong** (outages measure reliability directly).  
  - **Data-Outcome Timing:** **Weak** — adoption dates far precede observed data; “event time” is not meaningful for many states.  
  - **Outcome Dilution:** **Marginal** (RPS affects generation mix gradually; outages are influenced by distribution networks too, so the signal may be diluted even with good data).  
- **Recommendation:** **SKIP** unless you redefine treatment to something observable in 2014–2022 (e.g., **major RPS tightening events**, renewable penetration thresholds, or interconnection/market reforms) with credible pre-periods.

---

### Summary

This batch has **one clearly fundable DiD concept (Idea 1)** if executed with careful timing and comparability checks. **Idea 4** is feasible and potentially insightful but needs validation and strong safeguards against selection/confounding. **Ideas 2, 3, and 5** fail on core DiD identification as currently written—especially **timing alignment and dilution** (Idea 5), **outcome-policy mismatch** (Idea 2), and **lack of pre-treatment data around adoption** (Idea 3).